Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function

Int J Cardiol. 2013 Nov 20;169(5):e84-6. doi: 10.1016/j.ijcard.2013.10.040.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / physiopathology
  • Digoxin / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Severity of Illness Index*
  • Ventricular Dysfunction, Left / drug therapy*
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Anti-Arrhythmia Agents
  • Digoxin